Urispas 200mg FC Tablet
PDF Leaflet Revision Date: 13 May 2013
Clinical Summary
Quick overview from the medicine insert
Indication
Antispasmodic action in urological disorders.
Dosage (summary)
Adults: One tablet three times a day.
Special Populations
- Elderly
- Children under 12
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Contraindications
- Hypersensitivity to flavoxate hydrochloride
- Pyloric or duodenal obstruction
- Obstructive intestinal lesions
- Achalasia
- Gastrointestinal haemorrhage
- Obstructive uropathies
Common side effects
- Drowsiness
- Blurred vision
- Dry mouth
- Nausea
- Fatigue
Counselling Points
- Take with caution if experiencing drowsiness.
- Not recommended for children under 12.
Serious warnings
- Drowsiness, blurred vision, or vertigo may impair ability to drive or operate machinery.
- Caution in patients with glaucoma.
Important Disclaimer
The Urispas 200mg FC Tablet professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
